Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors

  • Eddy J. Chen
  • , Adam G. Sowalsky
  • , Shuai Gao
  • , Changmeng Cai
  • , Olga Voznesensky
  • , Rachel Schaefer
  • , Massimo Loda
  • , Lawrence D. True
  • , Huihui Ye
  • , Patricia Troncoso
  • , Rosina L. Lis
  • , Philip W. Kantoff
  • , Robert B. Montgomery
  • , Peter S. Nelson
  • , Glenn J. Bubley
  • , Steven P. Balk
  • , Mary Ellen Taplin

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1273-1280
Number of pages8
JournalClinical Cancer Research
Volume21
Issue number6
DOIs
StatePublished - Mar 15 2015

ASJC Scopus Subject Areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors'. Together they form a unique fingerprint.

Cite this